180 related articles for article (PubMed ID: 1282171)
1. Differential effects of nitrovasodilators, K(+)-channel openers, and nicorandil on large and small coronary arteries in conscious dogs.
Berdeaux A; Drieu la Rochelle C; Richard V; Giudicelli JF
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S17-21. PubMed ID: 1282171
[TBL] [Abstract][Full Text] [Related]
2. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
3. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
Imagawa J; Akima M; Nabata H; Taira N
J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.
Nakae I; Quan L; Hashimoto K; Sugimoto Y; Tsutamoto T; Kinoshita M
Cardiovasc Drugs Ther; 1994 Feb; 8(1):137-45. PubMed ID: 8086324
[TBL] [Abstract][Full Text] [Related]
5. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
Yoneyama F; Satoh K; Taira N
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1119-26. PubMed ID: 2150593
[TBL] [Abstract][Full Text] [Related]
6. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
[TBL] [Abstract][Full Text] [Related]
7. Potassium channel openers dilate large epicardial coronary arteries in conscious dogs by an indirect, endothelium-dependent mechanism.
la Rochelle CD; Richard V; Dubois-Randé JL; Roupie E; Giudicelli JF; Hittinger L; Berdeaux A
J Pharmacol Exp Ther; 1992 Dec; 263(3):1091-6. PubMed ID: 1469622
[TBL] [Abstract][Full Text] [Related]
8. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
Satoh K; Yamada H; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
[TBL] [Abstract][Full Text] [Related]
9. Nicorandil as a nitrate, and cromakalim as a potassium channel opener, dilate isolated porcine large coronary arteries in an agonist-nonselective manner.
Satoh K; Mori T; Yamada H; Taira N
Cardiovasc Drugs Ther; 1993 Aug; 7(4):691-9. PubMed ID: 8241013
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: comparison with other NO donors.
Matsumoto T; Takahashi M; Omura T; Takaoka A; Liu Q; Nakae I; Kinoshita M
J Cardiovasc Pharmacol; 1997 Jun; 29(6):772-9. PubMed ID: 9234658
[TBL] [Abstract][Full Text] [Related]
11. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
Giudicelli JF; la Rochelle CD; Berdeaux A
J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
[TBL] [Abstract][Full Text] [Related]
12. Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine.
Shen YT; Vatner SF
J Pharmacol Exp Ther; 1993 May; 265(2):1026-37. PubMed ID: 8496801
[TBL] [Abstract][Full Text] [Related]
13. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
14. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
McPherson GA; Stork AP
Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of vasodilation of cerebral vessels induced by the potassium channel opener nicorandil in canine in vivo experiments.
Ishiyama T; Dohi S; Iida H; Akamatsu S; Ohta S; Shimonaka H
Stroke; 1994 Aug; 25(8):1644-50. PubMed ID: 8042218
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
Yanagisawa T; Teshigawara T; Taira N
Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium.
Ghaleh B; Dubois-Randé JL; Hittinger L; Giudicelli JF; Berdeaux A
Br J Pharmacol; 1995 Jan; 114(2):496-502. PubMed ID: 7881748
[TBL] [Abstract][Full Text] [Related]
18. Effect of JTV-506, a novel vasodilator, on coronary blood flow in conscious dogs.
Hirata Y; Aisaka K
J Cardiovasc Pharmacol; 1997 Mar; 29(3):397-405. PubMed ID: 9125679
[TBL] [Abstract][Full Text] [Related]
19. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
Abe S; Nishimura J; Nakamura M; Kanaide H
J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil.
Holzmann S; Kukovetz WR; Braida C; Pöch G
Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
